X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

DRUG DELIVERY

期刊標題檢索 DRUG DELIV 最新評論: Submitted in May 25th, 25 years ago, with a bunch of ethical require... (2026-01-16)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[DRUG DELIVERY]您好,您是該頁面的第 184321 位訪客。

期刊簡介
期刊名稱DRUG DELIVERY DRUG DELIVERY
LetPub Score
6.9
50 ratings
Rate

Reputation
7.7

Influence
6.2

Speed
8.4

期刊簡稱DRUG DELIV
ISSN1071-7544
E-ISSN1521-0464
h-index52
CiteScore
CiteScoreSJRSNIPCiteScore Rank
16.401.3801.265
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q17 / 185

自引率 (2023-2024)1.50%自引率趨勢
掲載範囲
Drug Delivery is an open access journal serving the academic and industrial communities with peer reviewed coverage of basic research, development, and application principles of drug delivery and targeting at molecular, cellular, and higher levels. Topics covered include all delivery systems including oral, pulmonary, nasal, parenteral and transdermal, and modes of entry such as controlled release systems; microcapsules, liposomes, vesicles, and macromolecular conjugates; antibody targeting; protein/peptide delivery; DNA, oligonucleotide and siRNA delivery. Papers on drug dosage forms and their optimization will not be considered unless they directly relate to the original drug delivery issues. Published articles present original research and critical reviews.
官方網站http://informahealthcare.com/drd
在線稿件提交https://mc.manuscriptcentral.com/udrd
開放訪問Yes
出版商Informa Healthcare
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年1993
每年文章數40每年文章數趨勢
黃金OA百分比99.53%
OA Related Info
APC: Yes( EUR2875; USD2990; GBP2392; )
APC waiver:Check Notes
Other charges: No
Keywords: drug delivery systems、drug targeting、pharmaceutical sciences
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ117/352
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1071-7544%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 3.0 month(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【DRUG DELIVERY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.00
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 23.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 36.00
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 25.70
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 26.20
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.50
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.60
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 14.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 12.80
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 14.40
    學科內最受檢索的期刊 頁面查看次數
    PHARMACEUTICAL BIOLOGY23306516
    BIOMEDICINE & PHARMACOTHERAPY514391
    PHYTOMEDICINE474407
    LIFE SCIENCES414692
    European Journal of Pharmacology345318
    PHARMACOLOGICAL RESEARCH307374
    International Journal of Pharmaceutics277231
    BIOCHEMICAL PHARMACOLOGY275184
    JOURNAL OF NATURAL PRODUCTS204477
    BRITISH JOURNAL OF PHARMACOLOGY182289
  •  

    DRUG DELIVERY DRUG DELIVERY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)
  [DRUG DELIVERY] 的評論撰寫評論
作者: 仲夏忆彤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-18 10:09:16 評論於
Have you submitted it for review now?
(0) 讚! | 仲夏忆彤

作者: Ivy Finger


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-09 09:38:03 評論於
Hello, I am the same. After a few days of submitting, it shows "decision pending" and then there is a shadow of the final decision. Does this mean it will be rejected?
(0) 讚! | Ivy Finger

作者: 书生傲冬


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-11 08:55:05 評論於
How long does it usually take for your articles to be reviewed?
(0) 讚! | 书生傲冬

作者: Elva Patrick


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-23 13:36:28 評論於
No, it is not true. The editor-in-chief will review it, and it will be published after approval from the editor
(0) 讚! | Elva Patrick

作者: 卧龙淑然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-14 22:28:12 評論於
My application also shows "decision pending" the day after I submitted it. Does it mean I was rejected?
(0) 讚! | 卧龙淑然

作者: TtLang


領域: 医学
審稿時間: 6.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-03 17:51:55 評論於
Hello, I would like to inquire if your submission was successful. Why is it that after I submitted my manuscript, it appears as gray?
(0) 讚! | TtLang

作者: Leo Montgomery


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-01-15 17:55:43 評論於
Sorry, I want to ask you something. Currently, my status is decision pending. Does this mean I will be rejected?
(0) 讚! | Leo Montgomery

作者: 北陆沛蓝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-25 22:00:47 評論於
How can I submit an article? Colleagues who have submitted before, could you please share your submission experience? Can you contact me?
(0) 讚! | 北陆沛蓝

作者: 辉夜碧秋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-16 22:12:51 評論於
Will I be kicked out for citing myself so high?
(0) 讚! | 辉夜碧秋

作者: 深渊逸翔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-02-21 15:13:57 評論於
Why can't I open the submission website of drug deliv? Experts, please provide the submission website
(0) 讚! | 深渊逸翔

作者: 202020


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2020-01-10 08:20:43 評論於
Submitted on January 3, and now with journal administrator on January 10. How long is this stage, everyone? I’m anxious to graduate! So panic!

(8) 讚! | 202020

作者: 江南芃芃


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-01-02 10:53:45 評論於
I submitted on January 3rd, but it is already January 10th and I am still with the journal administrator. How long does this stage usually take? I'm anxious to graduate!
(0) 讚! | 江南芃芃

作者: 咏春承嗣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-12-06 20:48:30 評論於
Review speed: 1.0
Experience sharing: How long does it usually take to wait for funding approval?
(0) 讚! | 咏春承嗣

作者: 星星点灯


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2019-12-06 10:02:31 評論於
How long do you need to wait for this payment status of “awaiting funding approval”?

(2) 讚! | 星星点灯

作者: 幸运加运气


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2019-11-14 13:17:34 評論於
The manuscript was submitted on November 9, and it has been 5 days now. The status has changed from With Journal Administrator at the beginning to Editor's Decision in Process. Excuse me, what is it? Does it mean the editor is deciding not to send it for review and reject it, or should there be another step? I am anxious.

(2) 讚! | 幸运加运气

作者: 是你的吉欣呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-11-08 09:20:30 評論於
Review Speed: 1.0
Experience Sharing: I submitted my manuscript on November 9th, and now it has been exactly 5 days. The status has changed from "with journal administrator" to "editor's decision in process". What does this mean? Does it mean that the editor has decided not to send it for review and will reject it, or is this just a normal step in the process? I am anxious
(0) 讚! | 是你的吉欣呀

作者: Athena Connor


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-04-01 16:35:14 評論於
Which district?
(0) 讚! | Athena Connor

作者: wenwenwang


領域: 医学
審稿時間: 5.0 month(s)
結果: 拒稿


撰寫評論

2019-02-18 17:47:44 評論於
It’s too pitted. It’s been submitted for a month. I haven’t found a reviewer yet. I can’t help but remind myself. I found three reviewers, and the review comments have written more than ten pages.It was longer than the article itself, and it took more than a month to refuse the manuscript.White toss for 3 months, too discriminating against the Chinese.
(0) 讚! | wenwenwang

作者: 法慧才良


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-02-18 15:06:19 評論於
So frustrating, submitted for a month and still couldn't find a reviewer. Couldn't help but push a little, and finally found three reviewers. The review feedback was over ten pages long, longer than the article itself. Waited for another month, only to receive a rejection. What a waste of three months, feels like discrimination against Chinese
(0) 讚! | 法慧才良

作者: 雷电惜真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-01-26 23:16:52 評論於
I have already received 2 articles, I have to say, the efficiency of the review is very high
(0) 讚! | 雷电惜真

作者: 坠星曼丝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-01-23 12:11:58 評論於
Has the final payment been made yet? It didn't take long, less than a month and a half. Who knows why there was no notification for payment, the publication has already been made online, why hasn't any email been sent for payment
(0) 讚! | 坠星曼丝

作者: 小风小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-12-13 09:04:53 評論於
Review Speed: 6.0 | Submission Hit Rate: 25.0
Experience Sharing: The first review took 2 months, with 4 reviewers providing very professional and detailed comments. Over 20 questions were raised, with a month given to address them. Due to not having enough time to conduct extra experiments, an extension was requested and granted for another month. The revised version was submitted two months later and accepted two weeks after that, totaling 5 months in review time. In the supplementary material, it was requested to upload the complete Western blot band
(0) 讚! | 小风小娘子

作者: 西域单阏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-09-18 11:43:37 評論於
Fast Review Speed
(0) 讚! | 西域单阏

作者: 飞龙灵蕊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-06-28 12:34:10 評論於
2017 IF fell by half
(0) 讚! | 飞龙灵蕊

作者: 779229498@qq.com


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2018-03-29 18:27:49 評論於
submission after the submission is very good, do not know 2018Is the annual impact factor very low?I hope to stay at 5 or more
(0) 讚! | 779229498@qq.com

首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)

開始撰寫 [DRUG DELIVERY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*